Changes associated with quitting cigarette smoking: the Framingham Study.
During the first 18 years of the Framingham Study there was a substantial decrease (39 per cent ) in the number of men smoking cigarettes and a moderate decrease (22 per cent) in the number of women smoking cigarettes. Except for a greater tendency of diabetic patients to quit smoking, there were no significant differences at baseline between smokers who quit and smokers who continued smoking. After quitting there was a short-term rise in weight for men. This rise led only to trivial changes in blood pressure and serum cholesterol levels. There was a beneficial impact on long-term vital capacity trends from quitting smoking.
D000328:Adult; D000367:Age Factors; D000428:Alcohol Drinking; D001786:Blood Glucose; D001794:Blood Pressure; D001835:Body Weight; D002784:Cholesterol / Q000097:blood*; D003920:Diabetes Mellitus; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008404:Massachusetts; D008875:Middle Aged; D012737:Sex Factors; D012907:Smoking / Q000453:epidemiology*; D014527:Uric Acid / Q000097:blood*; D014797:Vital Capacity
D001786:Blood Glucose; D014527:Uric Acid; D002784:Cholesterol